Perbedaan Lippo Karawaci Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Lippo Karawaci Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 4,25 T, volume 24 jam 148,64 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Lippo Karawaci Tbk. jauh lebih besar — sekitar 25,4× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Lippo Karawaci Tbk. lebih aktif diperdagangkan (148,64 jt vs 96,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LPKR | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 4,25 T | 167,37 M |
Volume | 148,64 jt | 96,7 rb |
Lot | 1,49 jt | 967 |
Perputaran | 9,21 M | 23,82 jt |
Harga Rata-rata | 61,95 | 246,34 |
Nilai Transaksi | 9,21 M | 23,82 jt |
Harga Ekuilibrium Indikatif | 63 | 248 |
Volume Ekuilibrium Indikatif | 18,08 rb | 41 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Selengkapnya di halaman LPKR →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →